In a recent study published in the journal eGastroenterology, researchers delved into the latest therapeutic strategies for managing inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. The paper discusses emerging treatments ranging from immune-modulating drugs and biologics to novel approaches like microRNA upregulators and stem cell therapies, highlighting the need for precision medicine in IBD care.
Affimed cuts up to 50% of employees to support clinical projects, CEO departs
Affimed is slashing its headcount by up to half as part of a broader reorganization aimed at supporting the company through its next round of
January 9, 2024